OPCON owner Contact Information online
from Bausch & Lomb Incorporated
OPCON
US serial number:85078169
Application filling date:Jul. 06, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Mar. 10, 2014
Publication date:Dec. 07, 2010
Abandoned date:Mar. 10, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: OPHTHALMIC PHARMACEUTICALS, NAMELY EYE DROPS, SOLUTIONS, GELS AND OINTMENTS USED FOR THE TREATMENT OF EYE CONDITIONS SUCH AS DRY EYES, ALLERGIES, INFLAMMATION, REDNESS AND ITCHY EYES
International Class(es): 005- Primary Class
U.S Class(es): 006,018,
Services:OPHTHALMIC PHARMACEUTICALS
NAMELY EYE DROPS
SOLUTIONS
GELS AND OINTMENTS USED FOR THE TREATMENT OF EYE CONDITIONS SUCH AS DRY EYES
ALLERGIES
INFLAMMATION
REDNESS AND ITCHY EYES
Current owner owner name:Bausch & Lomb Incorporated
Current owner owner address:Law Department
One Bausch & Lomb Place
Rochester,
NEW YORK
UNITED STATES
146042701
Current owner legal entity type:CORPORATION
Current owner state or country:NEW YORK
Correspondent name address:BAUSCH & LOMB INCORPORATED
BAUSCH & LOMB INCORPORATED
1 BAUSCH AND LOMB PL
ROCHESTER,
NEW YORK
UNITED STATES
14604-2799
Correspondent phone:585-338-8318
Correspondent email:nancy.sheller@bausch.com
Correspondent fax:585-338-8706
Correspondent email authorized:Yes
Trademark staff tm attorney:AGOSTO, GISELLE MARIE
Trademark staff law office assigned OPCON:LAW OFFICE 102
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Dec. 07, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
